Speaker illustration

Doctor Alberto Giannoni

Sant'Anna School of Advanced Studies, Pisa (Italy)

I am Assistant Professor at Scuola Superiore Sant’Anna (SSSA), Pisa, Italy and Consultant Cardiologist at the Cardiology and Cardiovascular Medicine Division, at Fondazione Toscana Gabriele Monasterio (FTGM), Pisa, Italy, a Research Hospital set up in collaboration with the Italian National Research Council and the Tuscany Regional Health System. My current clinical interests cover the spectrum of medical management of cardiovascular diseases, in particular coronary heart disease, myopathies and cardiomyopathies, heart failure (HF) and arrhythmias, with a focus on juvenile sudden death. Since ever, my research activity has been characterized by a translational approach and has focused on brain-heart interactions and on the neuroendocrine control of cardiovascular and respiratory function in health and disease, namely in HF, with particular attention to the study of pathophysiology of visceral feed-backs, such as chemoreflex, baroreflex and ergoreflex, and central apneas.

Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure

Event: ESC Congress 2022

Topic: Imaging

Session: Chronic heart failure - Imaging

Thumbnail

Clinical and prognostic significance of left ventricular outflow tract velocity time integral (LVOT-VTI) in patients with chronic heart failure

Event: ESC Congress 2022

Topic: Imaging

Session: Chronic heart failure - Imaging

Thumbnail

Haemodynamic forces as predictors of cardiac remodelling and outcome in heart failure with reduced ejection fraction treated with sacubitril/valsartan

Event: ESC Congress 2022

Topic: Imaging

Session: Heart failure pharmacotherapy - Sacubitril/valsartan

Thumbnail

Chemoreflex and baroreflex dysfunction still predict cardiovascular mortality and hospitalizations in patients with systolic heart failure and up-to-date treatment

Event: Heart Failure 2021

Topic: Pathophysiology

Session: ePoster session

Thumbnail

Central apneas and Ticagrelor related dyspnea in patients with acute coronary syndrome

Event: ESC Congress 2020

Topic: Treatment

Session: Acute Coronary Syndromes ePosters

Thumbnail

Benefit of buspirone on chemoreflex and central apneas in heart failure

Event: Heart Failure 2019

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

CMR in heart failure: detecting inflammation and fibrosis.

Event: Heart Failure 2019

Topic: Imaging

Session: Multimodality imaging in heart failure

Thumbnail

Plant Gain, Chemoreflex Gain, Circulation Time and Cheyne-Stokes Respiration in Heart Failure

Event: Heart Failure 2019

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

Haemodynamic changes associated with Cheyne-Stokes respiration in patients with heart failure: an echocardiographic study

Event: Heart Failure 2018

Topic: Haemodynamics of Heart Failure

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb